Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AT-101 in Recurrent Glioblastoma Multiforme
NCT00540722Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2008
- Primary completion
- Jun 2012
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of r-(-)-gossypol acetic acid in glioblastoma multiforme (GBM), sponsored by National Cancer Institute. Started Jan 2008; status: completed.
02
Drugs
r-(-)-gossypol acetic acid
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00540722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00540722.